YVONNE SADA to Humans
This is a "connection" page, showing publications YVONNE SADA has written about Humans.
Connection Strength
0.279
-
Survival outcomes in veterans with hepatocellular carcinoma, with and without HIV infection. AIDS. 2023 07 15; 37(9):1387-1397.
Score: 0.023
-
Care transitions: opportunities to better serve the traveling patient. Am J Manag Care. 2021 11; 27(11):461-462.
Score: 0.021
-
A Dozen Eggs. J Clin Oncol. 2021 11 10; 39(32):3645-3646.
Score: 0.020
-
Harnessing digital health to objectively assess cancer-related fatigue: The impact of fatigue on mobility performance. PLoS One. 2021; 16(2):e0246101.
Score: 0.020
-
Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 08; 19(8):1679-1687.
Score: 0.019
-
Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma. J Natl Compr Canc Netw. 2019 02; 17(2):161-168.
Score: 0.017
-
National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer. J Surg Res. 2019 05; 237:41-49.
Score: 0.017
-
Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. J Surg Res. 2018 06; 226:15-23.
Score: 0.016
-
Validation of Case Finding Algorithms for Hepatocellular Cancer From Administrative Data and Electronic Health Records Using Natural Language Processing. Med Care. 2016 Feb; 54(2):e9-14.
Score: 0.014
-
Primary care and communication in shared cancer care: a qualitative study. Am J Manag Care. 2011 Apr; 17(4):259-65.
Score: 0.010
-
Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer. Sci Rep. 2024 01 31; 14(1):2612.
Score: 0.006
-
A Multi-Institutional Natural Language Processing Pipeline to Extract Performance Status From Electronic Health Records. Cancer Control. 2024 Jan-Dec; 31:10732748241279518.
Score: 0.006
-
Using Telemedicine to Facilitate Patient Communication and Treatment Decision-Making Following Multidisciplinary Tumor Board Review for Patients with Hepatocellular Carcinoma. J Gastrointest Cancer. 2023 Jun; 54(2):623-631.
Score: 0.005
-
The detrimental association between fear of falling and motor performance in older cancer patients with chemotherapy-induced peripheral neuropathy. Gait Posture. 2021 07; 88:161-166.
Score: 0.005
-
Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer. J Surg Oncol. 2021 May; 123(8):1724-1735.
Score: 0.005
-
Hospital clinical staging accuracy for upper gastrointestinal malignancy. J Surg Oncol. 2020 Dec; 122(8):1630-1638.
Score: 0.005
-
Cancer-related cognitive impairment and associated factors in a sample of older male oral-digestive cancer survivors. Psychooncology. 2019 07; 28(7):1551-1558.
Score: 0.004
-
Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN. J Geriatr Oncol. 2019 11; 10(6):960-967.
Score: 0.004
-
Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019 04; 157(4):1682-1693.e1.
Score: 0.004
-
Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
Score: 0.004
-
Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci. 2018 05; 63(5):1173-1181.
Score: 0.004
-
National Quality Forum Colon Cancer Quality Metric Performance: How Are Hospitals Measuring Up? Ann Surg. 2017 12; 266(6):1013-1020.
Score: 0.004
-
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer. 2018 Jan 01; 124(1):74-83.
Score: 0.004
-
Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer. Ann Surg. 2017 08; 266(2):297-304.
Score: 0.004
-
Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
Score: 0.004
-
Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder. J Immunother. 2017 04; 40(3):114-116.
Score: 0.004
-
Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort. J Hepatol. 2016 12; 65(6):1148-1154.
Score: 0.004
-
Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. Aliment Pharmacol Ther. 2016 Mar; 43(5):621-30.
Score: 0.003
-
Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. J Surg Res. 2016 Feb; 200(2):552-9.
Score: 0.003
-
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):124-31.e1.
Score: 0.003
-
Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol. 2015 Mar; 13(3):594-601.e1.
Score: 0.003
-
Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology. 2013 May; 57(5):1858-68.
Score: 0.003
-
The effect of age and comorbidity on patient-centered health outcomes in patients receiving adjuvant chemotherapy for colon cancer. J Geriatr Oncol. 2013 Apr; 4(2):99-106.
Score: 0.003
-
Vandetanib for the treatment of lung cancer. Expert Opin Investig Drugs. 2012 Aug; 21(8):1211-21.
Score: 0.003
-
A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat. 2012 Apr; 132(3):993-1000.
Score: 0.003
-
"What bothers you the most?" Initial responses from patients receiving palliative care consultation. Am J Hosp Palliat Care. 2008 Apr-May; 25(2):88-92.
Score: 0.002